Design and synthesis of conformationally-constrained MMP inhibitors

M G Natchus1, M Cheng, C T Wahl

  • 1Procter and Gamble Pharmaceuticals, Health Care Research Center, Mason, OH 45040, USA.

Summary

Researchers identified new matrix metalloprotease inhibitors with potencies influenced by specific chemical structures. The caprolactam ring and succinate group substitutions significantly impacted inhibitor effectiveness.

Related Concept Videos